Every CVE Search/ Get API key

CVE-2023-31923

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web...

8.8 High

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

Attack profile

How easy it is to exploit

Attack vector
Network
Complexity
Low
Privileges needed
Low
User interaction
None

What an attacker can affect

Confidentiality
High
Integrity
High
Availability
High

Exploit likelihood

0.86%Up 0.8 points since May 23, 2023
90%50%10%1%

What each source reports

NVD Score used 8.8

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

Record
CVE-2023-31923
CVSS 3.1
8.8 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness
CWE-281
Updated
2026-11-02
CVE List No score

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

Record
CVE-2023-31923
Updated
2026-11-02
EUVDEUVD-2023-36212 No score

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

Record
EUVD-2023-36212
Updated
2026-11-03
GitHub AdvisoriesGHSA-q32m-5wqx-f57m 8.8

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web...

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

Record
GHSA-q32m-5wqx-f57m
CVSS 3.1
8.8 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness
CWE-281
Updated
2026-11-02

Affected products

History

History
RecordedChangedSources
aliasesEUVD
first indexedCVE List, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2023-31923 is a high vulnerability (CVSS 8.8) in Supremainc Biostar 2, published May 22, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.86%, the 58th percentile. No source names a fixed version.

References

MoveEnter Open